Michael L Matson1, Carlos H Villa2, Jeyarama S Ananta3, Justin J Law1, David A Scheinberg2, Lon J Wilson4. 1. Department of Chemistry, and the Smalley Institute for Nanoscale Science and Technology, Rice University, Houston, Texas. 2. Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, New York; and. 3. Department of Chemistry, and the Smalley Institute for Nanoscale Science and Technology, Rice University, Houston, Texas Molecular Imaging Program at Stanford University, Department of Radiology, Stanford University, Stanford, California. 4. Department of Chemistry, and the Smalley Institute for Nanoscale Science and Technology, Rice University, Houston, Texas durango@rice.edu.
Abstract
UNLABELLED: (225)Ac(3+) is a generator of α-particle-emitting radionuclides with 4 net α-particle decays that can be used therapeutically. Targeting (225)Ac(3+) by use of ligands conjugated to traditional bifunctional chelates limits the amount of (225)Ac(3+) that can be delivered. Ultrashort, single-walled carbon nanotubes (US-tubes), previously demonstrated as sequestering agents of trivalent lanthanide ions and small molecules, also successfully incorporate (225)Ac(3+). METHODS: Aqueous loading of both (225)Ac(3+) ions and Gd(3+) ions via bath sonication was used to construct (225)Ac@gadonanotubes ((225)Ac@GNTs). The (225)Ac@GNTs were subsequently challenged with heat, time, and human serum. RESULTS: US-tubes internally loaded with both (225)Ac(3+) ions and Gd(3+) ions show 2 distinct populations of (225)Ac(3+) ions: one rapidly lost in human serum and one that remains bound to the US-tubes despite additional challenge with heat, time, and serum. The presence of the latter population depended on cosequestration of Gd(3+) and (225)Ac(3+) ions. CONCLUSION: US-tubes successfully sequester (225)Ac(3+) ions in the presence of Gd(3+) ions and retain them after a human serum challenge, rendering (225)Ac@GNTs candidates for radioimmunotherapy for delivery of (225)Ac(3+) ions at higher concentrations than is currently possible for traditional ligand carriers.
UNLABELLED: (225)Ac(3+) is a generator of α-particle-emitting radionuclides with 4 net α-particle decays that can be used therapeutically. Targeting (225)Ac(3+) by use of ligands conjugated to traditional bifunctional chelates limits the amount of (225)Ac(3+) that can be delivered. Ultrashort, single-walled carbon nanotubes (US-tubes), previously demonstrated as sequestering agents of trivalent lanthanide ions and small molecules, also successfully incorporate (225)Ac(3+). METHODS: Aqueous loading of both (225)Ac(3+) ions and Gd(3+) ions via bath sonication was used to construct (225)Ac@gadonanotubes ((225)Ac@GNTs). The (225)Ac@GNTs were subsequently challenged with heat, time, and human serum. RESULTS: US-tubes internally loaded with both (225)Ac(3+) ions and Gd(3+) ions show 2 distinct populations of (225)Ac(3+) ions: one rapidly lost in human serum and one that remains bound to the US-tubes despite additional challenge with heat, time, and serum. The presence of the latter population depended on cosequestration of Gd(3+) and (225)Ac(3+) ions. CONCLUSION: US-tubes successfully sequester (225)Ac(3+) ions in the presence of Gd(3+) ions and retain them after a human serum challenge, rendering (225)Ac@GNTs candidates for radioimmunotherapy for delivery of (225)Ac(3+) ions at higher concentrations than is currently possible for traditional ligand carriers.
Authors: Jelena Kolosnjaj-Tabi; Keith B Hartman; Sabah Boudjemaa; Jeyarama S Ananta; Georges Morgant; Henri Szwarc; Lon J Wilson; Fathi Moussa Journal: ACS Nano Date: 2010-03-23 Impact factor: 15.881
Authors: B Sitharaman; K R Kissell; K B Hartman; L A Tran; A Baikalov; I Rusakova; Y Sun; H A Khant; S J Ludtke; W Chiu; S Laus; E Tóth; L Helm; A E Merbach; L J Wilson Journal: Chem Commun (Camb) Date: 2005-07-08 Impact factor: 6.222
Authors: Brandon T Cisneros; Justin J Law; Michael L Matson; Ali Azhdarinia; Eva M Sevick-Muraca; Lon J Wilson Journal: Nanomedicine (Lond) Date: 2014-11 Impact factor: 5.307
Authors: Amy A Hassan; Bonita Tak-Yee Chan; Lesa A Tran; Keith B Hartman; Jeyarama S Ananta; Yuri Mackeyev; Lingyun Hu; Robia G Pautler; Lon J Wilson; Adrian V Lee Journal: Contrast Media Mol Imaging Date: 2010 Jan-Feb Impact factor: 3.161
Authors: Michael R McDevitt; Debjit Chattopadhyay; Barry J Kappel; Jaspreet Singh Jaggi; Scott R Schiffman; Christophe Antczak; Jon T Njardarson; Renier Brentjens; David A Scheinberg Journal: J Nucl Med Date: 2007-07 Impact factor: 11.082
Authors: Mohamed M Swidan; Omnya M Khowessah; Mohamed Abd El-Motaleb; Ahmed Abd El-Bary; Mohamed T El-Kolaly; Tamer M Sakr Journal: Daru Date: 2019-01-31 Impact factor: 3.117
Authors: Narges K Tafreshi; Michael L Doligalski; Christopher J Tichacek; Darpan N Pandya; Mikalai M Budzevich; Ghassan El-Haddad; Nikhil I Khushalani; Eduardo G Moros; Mark L McLaughlin; Thaddeus J Wadas; David L Morse Journal: Molecules Date: 2019-11-26 Impact factor: 4.411
Authors: Andrés Rodríguez-Galván; Margarita Rivera; Patricia García-López; Luis A Medina; Vladimir A Basiuk Journal: J Cell Mol Med Date: 2020-03-10 Impact factor: 5.310